119 related articles for article (PubMed ID: 21615395)
1. In vitro responsiveness of human muscle cell peroxisome proliferator-activated receptor δ reflects donors' insulin sensitivity in vivo.
Ordelheide AM; Heni M; Thamer C; Machicao F; Fritsche A; Stefan N; Häring HU; Staiger H
Eur J Clin Invest; 2011 Dec; 41(12):1323-9. PubMed ID: 21615395
[TBL] [Abstract][Full Text] [Related]
2. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.
Staiger H; Haas C; Machann J; Werner R; Weisser M; Schick F; Machicao F; Stefan N; Fritsche A; Häring HU
Diabetes; 2009 Mar; 58(3):579-89. PubMed ID: 19074989
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
4. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
[TBL] [Abstract][Full Text] [Related]
5. Human skeletal muscle PPARalpha expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity.
Zhang J; Phillips DI; Wang C; Byrne CD
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E168-75. PubMed ID: 14519597
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
Hu C; Jia W; Fang Q; Zhang R; Wang C; Lu J; Xiang K
Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
Robciuc MR; Skrobuk P; Anisimov A; Olkkonen VM; Alitalo K; Eckel RH; Koistinen HA; Jauhiainen M; Ehnholm C
PLoS One; 2012; 7(10):e46212. PubMed ID: 23056264
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
Chen W; Wang LL; Liu HY; Long L; Li S
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):240-6. PubMed ID: 18684227
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
[TBL] [Abstract][Full Text] [Related]
10. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
[TBL] [Abstract][Full Text] [Related]
11. [Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1 in liver and skeletal muscle and its influence on insulin sensitivity].
Bai XP; Li HL; Yang WY; Xiao JZ; Wang B; Du RQ; Lou DJ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):268-70. PubMed ID: 18361841
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
Risérus U; Sprecher D; Johnson T; Olson E; Hirschberg S; Liu A; Fang Z; Hegde P; Richards D; Sarov-Blat L; Strum JC; Basu S; Cheeseman J; Fielding BA; Humphreys SM; Danoff T; Moore NR; Murgatroyd P; O'Rahilly S; Sutton P; Willson T; Hassall D; Frayn KN; Karpe F
Diabetes; 2008 Feb; 57(2):332-9. PubMed ID: 18024853
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholines activate PPARδ and protect human skeletal muscle cells from lipotoxicity.
Klingler C; Zhao X; Adhikary T; Li J; Xu G; Häring HU; Schleicher E; Lehmann R; Weigert C
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1980-1992. PubMed ID: 27697477
[TBL] [Abstract][Full Text] [Related]
14. PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.
Feng YZ; Nikolić N; Bakke SS; Boekschoten MV; Kersten S; Kase ET; Rustan AC; Thoresen GH
Arch Physiol Biochem; 2014 Feb; 120(1):12-21. PubMed ID: 23991827
[TBL] [Abstract][Full Text] [Related]
15. Evidence against a sexual dimorphism in glucose and fatty acid metabolism in skeletal muscle cultures from age-matched men and post-menopausal women.
Rune A; Salehzadeh F; Szekeres F; Kühn I; Osler ME; Al-Khalili L
Acta Physiol (Oxf); 2009 Nov; 197(3):207-15. PubMed ID: 19508405
[TBL] [Abstract][Full Text] [Related]
16. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
Dimopoulos N; Watson M; Green C; Hundal HS
FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
[TBL] [Abstract][Full Text] [Related]
17. Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects.
Majer M; Popov KM; Harris RA; Bogardus C; Prochazka M
Mol Genet Metab; 1998 Oct; 65(2):181-6. PubMed ID: 9787110
[TBL] [Abstract][Full Text] [Related]
18. JNK deficiency enhances fatty acid utilization and diverts glucose from oxidation to glycogen storage in cultured myotubes.
Vijayvargia R; Mann K; Weiss HR; Pownall HJ; Ruan H
Obesity (Silver Spring); 2010 Sep; 18(9):1701-9. PubMed ID: 20094041
[TBL] [Abstract][Full Text] [Related]
19. Regulation of skeletal muscle PPAR delta mRNA expression in twins.
Nilsson E; Poulsen P; Sjögren M; Ling C; Ridderstråle M; Groop L; Vaag A
J Physiol; 2007 Nov; 584(Pt 3):1011-7. PubMed ID: 17855759
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
